Forward P/S Multiple: Cutera (CUTR)

Cutera, Inc. - graphic logo of issuer CUTR

Cutera, Inc. (CUTR) has stabilized liquidity through strict resource austerity. Growth is driven by the innovative AviClear device and cost reductions. The expected P/S ratio reflects market sentiment, where the level of 0.00 is the current value. An aggressive corporate culture and high bonuses retain top engineers, confirming the development potential shown on this chart.

cutera.com - CUTR Market Cap to Projected Revenue (period 07/04/2022 - 03/22/2025)

Summary analytical data breakdowns for Cutera Inc (CUTR)

- market price and analyst price targets:
Price Chart Cutera|CUTR - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Cutera Inc|CUTR - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Cutera|CUTR - Accounting Capitalization|Market Capitalization to Book Value Ratio cutera.com|CUTR - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Cutera, Inc.|CUTR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Cutera, Inc.|CUTR - Company Aggregate Debts|Debt to Book Capitalization Ratio Cutera Inc|CUTR - Company Long-Term Debt|Company Current Liabilities Cutera|Quick Ratio cutera.com
- financial results and valuation multiples details:
CUTR - Company Net Income|Expected Profit Cutera, Inc.|CUTR - Market Cap to Net Income Ratio|Projected Price to Earnings Cutera, Inc|CUTR - PEG Multiple|EV/EBITDA Multiple Cutera Inc|CUTR - Operating income before deduction of amortization|Earnings per share for the last twelve months Cutera|CUTR - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months cutera.com|CUTR - Net earnings per share growth this year|Earnings growth forecast for next year Cutera, Inc.
- sales and revenue indicators:
CUTR - Company Total Revenue|Company Projected Revenue Cutera|CUTR - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Cutera Inc
Fundamental company analysis:CUTR (Cutera)
Product sample of Cutera Inc

The assessment of Cutera, Inc. (CUTR) operational resilience is based on comparing market value with expected sales volume, which determines the premium paid for future growth. This forward P/S ratio for Cutera, Inc. (CUTR) measures the ratio of market capitalization to planned revenue from the sale of aesthetic equipment and consumables, reflecting market expectations for the expansion of Cutera, Inc. (CUTR) in the dermatology segment through the price action on the chart.

Who Cutera, Inc. competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|Forward Price-to-Revenue Multiple Beyond Air|Forward Price-to-Revenue Multiple PFSA|Forward P/S Multiple STRATA Skin|Forward Price-to-Revenue Multiple GCTK (GlucoTrack)|Price to Expected Revenue Ratio NAOV|Forward P/S Multiple VERO (Venus Concept Inc.)|nuwellis.com (NUWE) - Market Cap to Future Revenue Ratio|AEMD - Price-to-Projected Revenue Ratio|Forward Price to Sales ASXC (Asensus Surgical, Inc.)|AVGR: Forward P/S Multiple|Biosig Technologies (BSGM) - Forward P/S Multiple|Forward Price-to-Revenue Multiple KNW|NARI: Forward Price to Sales|Forward P/S Multiple NVRO|Market Cap to Expected Sales Ratio reshapelifesciences.com|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK